報價延遲最少15分鐘:2025/07/07 05:45 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.3 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.99/-0.71
|
|
企業價值
1.04B
|
| 資產負債 |
|
每股賬面淨值
1.76
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/07 05:45 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. |